A retrospective analysis on the lung cancer specimens for Oncomine Dx Target Test in Keio University Hospital

A retrospective analysis on the lung cancer specimens for Oncomine Dx Target Test in Keio University Hospital - A retrospective analysis on the lung cancer specimens for ODxTT in Keio University Hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050424

Enrollment

500

Registered

2023-02-25

Start date

2020-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer (NSCLC)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Cases with a confirmed diagnosis of histologically unresectable advanced or recurrent non-small cell lung cancer 2. Cases with ODxTT testing performed between May 2020 and October 2022

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The success rate of driver gene mutation detection in the Oncomine Dx Target Test multi-CDx system	—

Countries

Japan,Asia(except Japan)

Contacts

Public ContactHideki Terai

Clinical Lung Cancer Genomics Research Group Cancer Center

hidekiterai@keio.jp03-5363-3793

Outcome results